BrainAurora Medical Technology Ltd. - B: insider trades · Hong Kong · HKEX HKEX:brainaurora-medical-technology-ltd-b HK HK · HKEX Mcap 4.1Bn€ Healthcare
Discover the full directors' dealings record of BrainAurora Medical Technology Ltd. - B, a listed equity based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, BrainAurora Medical Technology Ltd. - B has published 9 reports. Market capitalisation: €4.1bn. The latest transaction was reported on 13 May 2026 — Purchase. Among the most active insiders: TAN Zheng. Every trade is free.
Financial data FY ended December 2025 · cache
Analyst consensus
1 analysts · 8.03 € Target 8.03 €(+163%) 8.03 €
Income statement
Revenue 220.0 M€
Gross profit 89.5 M€ 41% margin
Net income −314.9 M€ -143.1% margin
Balance sheet & cash
Market cap 4.14 Bn€
Total debt 565.5 M€
Free Cash Flow −205.7 M€
Debt / Equity 592%
Profitability & ownership
ROA -27.3%
% insiders 76.4%
% institutions 9.3%
Last declaration on 13 May 2026
Declarations 9 total
Executives ● Purchase5 HKEX
€205,801 500,000 shares @ €0.4116 0.0050% mcap 21.8% of flow
HKEX:DA20260513E00191 · 12 May 2026
Ideal exit: 6 Feb 2027 (T+270) Executives ● Purchase6 HKEX
€236,237 549,000 shares @ €0.4303 0.0057% mcap 25.1% of flow
HKEX:DA20260507E00021 · 4 May 2026
Ideal exit: 29 Jan 2027 (T+270) Executives ● Purchase4 HKEX
€62,088 150,000 shares @ €0.4139 0.0015% mcap 6.6% of flow
HKEX:DA20260507E00024 · 5 May 2026
Ideal exit: 30 Jan 2027 (T+270) Executives ● Purchase4 HKEX
€82,374 200,000 shares @ €0.4119 0.0020% mcap 8.7% of flow
HKEX:DA20260430E00351 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase3 HKEX
€41,013 96,000 shares @ €0.4272 0.0010% mcap 4.4% of flow
HKEX:DA20260428E00292 · 27 Apr 2026
Ideal exit: 22 Jan 2027 (T+270) Executives ● Purchase4 HKEX
€86,695 200,000 shares @ €0.4335 0.0021% mcap 9.2% of flow
HKEX:DA20260428E00290 · 24 Apr 2026
Ideal exit: 19 Jan 2027 (T+270) Executives ● Sale3 HKEX
123,527,000 shares
HKEX:DA20260424E00670 · 16 Apr 2026
Executives ● Purchase5 HKEX
€181,764 403,000 shares @ €0.451 0.0044% mcap 19.3% of flow
HKEX:DA20260421E00444 · 17 Apr 2026
Ideal exit: 12 Jan 2027 (T+270) Executives ● Purchase3 HKEX
€46,108 101,000 shares @ €0.4565 0.0011% mcap 4.9% of flow
HKEX:DA20260421E00441 · 16 Apr 2026
Ideal exit: 11 Jan 2027 (T+270)